Collaborate Disseminate
Science and engineering usually create consistent results. Generally, when you figure out how to make something, you can repeat that at will to make more of something. But what if, …read more Continue reading The Rise of The Disappearing Polymorphs
Data breaches are both commonplace and costly in the medical industry. Two industry verticals that fall under the medical umbrella — healthcare and pharmaceuticals — sit at the top of the list of the highest average cost of a data breach, according to IBM’s Cost of a Data Breach Report 2023. The health industry’s place […]
The post Cost of a data breach 2023: Pharmaceutical industry impacts appeared first on Security Intelligence.
Continue reading Cost of a data breach 2023: Pharmaceutical industry impacts
To the uninitiated, it might seem like a gimmick to 3D print pharmaceuticals. After all, you take some kind of medicine, pour it in a mold, and you have a …read more Continue reading 3D Printing Pills All At Once
Its natural language processing platform aids subject-matter experts in finding answers to their questions. Continue reading AI startup Sorcero secures $10M for language intelligence platform
Bringing order and understanding to unstructured information located across disparate silos has been one of more significant breakthroughs of the big data era, and today a European startup that has built a platform to help with this challenge specifically in the area of life sciences — and has, notably, been used by labs to sequence […] Continue reading Seqera Labs grabs $5.5M to help sequence Covid-19 variants and other complex data problems
When you’ve got a diabetic in your life, there are few moments in any day that are free from thoughts about insulin. Insulin is literally the first coherent thought I …read more Continue reading Open-Source Insulin: Biohackers Aiming for Distributed Production
Love it or loathe it, the pharmaceutical industry is really good at protecting its intellectual property. Drug companies pour billions into discovering new drugs and bringing them to market, and they do whatever it takes to make sure they have exclusive positions to profit from their innovations for as long a possible. Patent applications are meticulously crafted to keep the competition at bay for as long as possible, which is why it often takes ages for cheaper generic versions of blockbuster medications to hit the market, to the chagrin of patients, insurers, and policymakers alike.
Drug companies now appear poised …read more
Continue reading AI Patent Trolls Now on the Job for Drug Companies
Love it or loathe it, the pharmaceutical industry is really good at protecting its intellectual property. Drug companies pour billions into discovering new drugs and bringing them to market, and they do whatever it takes to make sure they have exclusive positions to profit from their innovations for as long a possible. Patent applications are meticulously crafted to keep the competition at bay for as long as possible, which is why it often takes ages for cheaper generic versions of blockbuster medications to hit the market, to the chagrin of patients, insurers, and policymakers alike.
Drug companies now appear poised …read more
Continue reading AI Patent Trolls Now on the Job for Drug Companies
We’ve covered construction of novel music instruments on these pages, and we’ve covered many people tearing down scientific instruments. But today we’ve got something that managed to cross over from one world of “instrument” into another: a music instrument modified to measure a liquid’s density by listening to changes in its pitch.
This exploration started with a mbira, a mechanically simple music instrument. Its row of rigid metal tines was replaced with a single small diameter hollow metal tube. Filling the tube with different liquids would result in different sounds. Those sounds are captured by a cell phone and processed …read more
Continue reading Sounding A Sour Note Can Save People From A Sour Stomach (Or Worse)
Drugs are used the world over to treat disease. However, from time to time, the vagaries of market economics, or unscrupulous action, can radically increase the price of otherwise cheap pharmaceuticals far beyond the reach of the average person. This was the case with Pyrimethamine (sold as Daraprim), which is used to treat toxoplasmosis and malaria, among other users. With the price skyrocketing from $13 to $750 a tablet in the US in 2015, [NerdRage] decided to synthesize the drug on their own. (If you missed the background hubbub, search for “Martin Shkreli”.)
The video linked covers the final synthesis, …read more
Continue reading Synthesizing Daraprim to Beat Price Gougers